Literature DB >> 31128888

Live-Animal Epigenome Editing: Convergence of Novel Techniques.

J Antonio Gomez1, Ulrika Beitnere1, David J Segal2.   

Abstract

Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR; animal models; cancer; delivery; epigenomic editing; neurodevelopment

Mesh:

Year:  2019        PMID: 31128888      PMCID: PMC6608710          DOI: 10.1016/j.tig.2019.04.007

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  77 in total

1.  Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.

Authors:  Patricia Colque-Navarro; Gunnar Jacobsson; Rune Andersson; Jan-Ingmar Flock; Roland Möllby
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

2.  Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system.

Authors:  Hongwei Zhang; Bin Yang; Xin Mu; Seemin Seher Ahmed; Qin Su; Ran He; Hongyan Wang; Christian Mueller; Miguel Sena-Esteves; Robert Brown; Zuoshang Xu; Guangping Gao
Journal:  Mol Ther       Date:  2011-05-24       Impact factor: 11.454

3.  Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice.

Authors:  Mireia Garriga-Canut; Carmen Agustín-Pavón; Frank Herrmann; Aurora Sánchez; Mara Dierssen; Cristina Fillat; Mark Isalan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-10       Impact factor: 11.205

4.  An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease.

Authors:  Josee Laganiere; Adrian P Kells; Jeffrey T Lai; Dmitry Guschin; David E Paschon; Xiangdong Meng; Lauren K Fong; Qi Yu; Edward J Rebar; Philip D Gregory; Krystof S Bankiewicz; John Forsayeth; H Steve Zhang
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

5.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

6.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

Review 7.  Viral vectors and delivery strategies for CNS gene therapy.

Authors:  Steven J Gray; Kenton T Woodard; R Jude Samulski
Journal:  Ther Deliv       Date:  2010-10

8.  CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.

Authors:  Luke A Gilbert; Matthew H Larson; Leonardo Morsut; Zairan Liu; Gloria A Brar; Sandra E Torres; Noam Stern-Ginossar; Onn Brandman; Evan H Whitehead; Jennifer A Doudna; Wendell A Lim; Jonathan S Weissman; Lei S Qi
Journal:  Cell       Date:  2013-07-11       Impact factor: 41.582

9.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962

10.  Optical control of mammalian endogenous transcription and epigenetic states.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro Trevino; Patrick D Hsu; Matthias Heidenreich; Le Cong; Randall J Platt; David A Scott; George M Church; Feng Zhang
Journal:  Nature       Date:  2013-08-23       Impact factor: 49.962

View more
  3 in total

1.  Patch-seq: Past, Present, and Future.

Authors:  Marcela Lipovsek; Cedric Bardy; Cathryn R Cadwell; Kristen Hadley; Dmitry Kobak; Shreejoy J Tripathy
Journal:  J Neurosci       Date:  2021-01-11       Impact factor: 6.167

2.  KRAB-Induced Heterochromatin Effectively Silences PLOD2 Gene Expression in Somatic Cells and is Resilient to TGFβ1 Activation.

Authors:  Rutger A F Gjaltema; Désirée Goubert; Christian Huisman; Consuelo Del Pilar García Tobilla; Mihály Koncz; Pytrick G Jellema; Dandan Wu; Uilke Brouwer; Antal Kiss; Pernette J Verschure; Ruud A Bank; Marianne G Rots
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 3.  The Epigenetics of Gametes and Early Embryos and Potential Long-Range Consequences in Livestock Species-Filling in the Picture With Epigenomic Analyses.

Authors:  Linkai Zhu; Sadie L Marjani; Zongliang Jiang
Journal:  Front Genet       Date:  2021-03-03       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.